Form 4: Orthopediatrics Corp. Director Acquires Shares

David R. Pelizzon, a Director at Orthopediatrics Corp., has acquired 11,436 shares of common stock.

Summary

• David R. Pelizzon, a Director at Orthopediatrics Corp. (KIDS), acquired 11,436 shares of common stock on June 9, 2026.
• Following this transaction, Pelizzon directly owns 44,384 shares.
• Additionally, Pelizzon may be deemed to beneficially own 6,901,764 shares held by Squadron Capital LLC, where he serves as President and a member of the Managing Committee. He expressly disclaims beneficial ownership of these shares except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a standard insider transaction without providing new financial or strategic information.

Positives

• Director acquisition of shares can signal confidence in the company's future prospects.
• The acquisition of 11,436 shares directly by a director is a tangible investment in the company.

Negatives

• The reporting person expressly disclaims beneficial ownership of a significant number of shares held by Squadron Capital LLC, indicating a potential separation of control and beneficial ownership for reporting purposes.

Risks

• The disclaimer of beneficial ownership for shares held by Squadron Capital LLC could introduce complexity in understanding ultimate control and influence over those securities.

Future Outlook

No specific forward-looking statements or guidance were provided in this Form 4 filing.

Management Comments

• The reporting person expressly disclaims beneficial ownership of these shares [held by Squadron Capital LLC], except to the extent of his pecuniary interest therein.
• The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose.

Industry Context

StockSavvy.ai notes that insider transactions, such as director share acquisitions, are closely watched by the market as potential indicators of management's view on the company's valuation and future performance within the competitive orthopedic medical device sector.

Related Party Transactions

• David R. Pelizzon, as President and a member of the Managing Committee of Squadron Capital LLC, may be deemed to beneficially own shares held by Squadron Capital LLC. He disclaims beneficial ownership except for his pecuniary interest.

Stakeholder Impact

• Shareholders: May interpret the director's share acquisition as a positive signal of confidence in the company's value.
• Management: The transaction is a personal investment by a director.

Next Steps

• Continued monitoring of insider transactions for further insights into management's investment activity.

Key Dates

Keywords

Orthopediatrics Corp, KIDS, Form 4, SEC Filing, Insider Trading, Director Transaction, Share Acquisition, Beneficial Ownership, Squadron Capital LLC